| View |
|
DRP-4298-02
|
Methotrexate
|
Omari Tab
|
2.5 mg
|
Tablet
|
Antineoplastic (Cell cycle-specific agent)
|
Khandelwal Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
24 September 2024
|
20 March 2028
|
| View |
|
DRP-5493-06
|
Etoricoxib
|
Rilaxia
|
120 mg
|
Film-Coated Tablet
|
Non-Steroidal Anti-Inflammatory Drug/NSAID (Coxib)
|
XL Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
27 September 2024
|
28 August 2029
|
| View |
|
DRP-15483-02
|
Dapagliflozin (as propanediol monohydrate)
|
Flosazin
|
10 mg
|
Film-Coated Tablet
|
Blood glucose lowering drug [Sodium-glucose co-transporter 2(SGLT2) Inhibitor]
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
24 September 2024
|
16 July 2029
|
| View |
|
DRP-15499-01
|
Atorvastatin (as calcium trihydrate)
|
Stadin
|
40 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitor
|
Lek S.A.
|
Poland
|
CLIDP Conversion
|
29 September 2024
|
29 July 2029
|
| View |
|
DRP-15483-03
|
Dapagliflozin (as propanediol monohydrate)
|
Cardiogly
|
10 mg
|
Film-Coated Tablet
|
Blood glucose lowering drug [Sodium-glucose co-transporter 2(SGLT2) Inhibitor]
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
27 September 2024
|
16 July 2029
|
| View |
|
DRP-15483-04
|
Dapagliflozin (as propanediol monohydrate)
|
None
|
10 mg
|
Film-Coated Tablet
|
Blood glucose lowering drug [Sodium-glucose transporter 2(SGLT2) Inhibitor]
|
Stallion Laboratories Pvt.Ltd.
|
India
|
CLIDP Conversion
|
27 September 2024
|
16 July 2029
|
| View |
|
DRP-15483-01
|
Dapagliflozin (as propanediol monohydrate)
|
SciGliFlo
|
10 mg
|
Film-Coated Tablet
|
Blood glucose lowering drug [Sodium-glucose co-transporter 2 (SGLT2) Inhibitor]
|
Stallion Laboratories Pvt.Ltd.
|
India
|
CLIDP Conversion
|
15 September 2024
|
16 July 2029
|
| View |
|
DRP-15585-01
|
Nystatin
|
Gozenyst
|
100,000 IU/mL
|
Oral Suspension
|
Antifungal
|
S Kant Healthcare Ltd.
|
India
|
CLIDP Conversion
|
27 September 2024
|
06 August 2029
|
| View |
|
DRP-15663-01
|
Losartan Potassium
|
Raptrasol
|
100 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
28 September 2024
|
16 August 2029
|
| View |
|
DRP-15500-01
|
Atorvastatin (as calcium trihydrate)
|
Stadin
|
20 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitor
|
Lek S.A.
|
Poland
|
CLIDP Conversion
|
29 September 2024
|
29 July 2029
|
| View |
|
DRP-15585-02
|
Nystatin
|
Retanyst
|
100,000 IU/mL
|
Oral Suspension
|
Antifungal
|
S Kant Healthcare Ltd.
|
India
|
CLIDP Conversion
|
23 September 2024
|
06 August 2029
|
| View |
|
DRP-15451-01
|
Clopidogrel (as bisulfate)
|
Plavicar
|
75 mg
|
Film Coated Tablet
|
Antithrombotic Agent
|
Hebei Tiancheng Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
27 September 2024
|
11 July 2029
|
| View |
|
DRP-15501-01
|
Atorvastatin (as calcium trihydrate)
|
Stadin
|
10 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitor
|
Lek S.A.
|
Poland
|
CLIDP Conversion
|
29 September 2024
|
29 July 2029
|
| View |
|
DRP-15663-02
|
Losartan Potassium
|
Losartap
|
100 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
28 September 2024
|
16 August 2029
|
| View |
|
DRP-8464
|
Salbutamol (as Sulfate) + Guaifenesin
|
Srilux Expectorant
|
1 mg / 50 mg per 5 mL
|
Syrup
|
Anti-Asthma / Expectorant
|
Morishita-Seggs Pharmaceuticals, Inc.
|
Philippines
|
Renewal
|
15 September 2024
|
03 September 2029
|
| View |
|
DRP-8514-06
|
Clopidogrel (as Bisulfate)
|
Ategra
|
75 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Platelet Aggregation Inhibitor)
|
Mepro Pharmaceuticals Private Limited
|
India
|
CLIDP Conversion
|
29 September 2024
|
22 November 2027
|
| View |
|
DRP-8065-03
|
Metformin Hydrochloride
|
Neoform® 500
|
500 mg
|
Film-Coated Tablet
|
Oral Hypoglycemic (Biguanide)
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
27 September 2024
|
06 May 2029
|
| View |
|
DRP-8164-01
|
Iron
|
None
|
65 mg (equivalent to 325 mg Ferrous Sulfate)
|
Tablet
|
Mineral (Hematinic)
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
15 September 2024
|
10 April 2026
|
| View |
|
DRP-7738-02
|
Epirubicin hydrochloride
|
Helem-100
|
100 mg
|
Lyophilized Powder for Solution for IV Infusion
|
Cytotoxic Antibiotic (Anthracycline)
|
Celon Laboratories Limited
|
India
|
CLIDP Conversion
|
27 September 2024
|
19 March 2028
|
| View |
|
DRP-6823-06
|
Neostigmine (as Methylsulfate)
|
Neostilex
|
500 mcg/mL
|
Solution for Injection (IM/IV/SC)
|
Cholinesterase Inhibitors
|
Tablets (India) Limited
|
India
|
CLIDP Conversion
|
24 September 2024
|
01 September 2028
|